SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
SAGENT PHARMACEUTICALS
(NQNM:SGNT Last Sale: 22.13 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (SGNT : $22.13)
$619 million Market Cap at September 12, 2013
Drugs SubIndustry up .00% / Health Industry up .00% Today

Research Report Earnings Snapshot - Last 11/04/18
Fact Sheet
Financial Statements
Peer Comparison
Annual Reports

Jeffrey Yordon, Pres./CEO
Focus on generic injectable pharmaceuticals. IPO at $16 April 19, 2011. Raised $92 million, selling 5.8 million shares, 21% of the outstanding. Lead Manager: Morgan Stanley.
Historical Charts    Technical Analysis
No Historical Data available for SGNT

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common SGNT $22.13 $ 0 $21.52 $22.305 544,828 $13.39 $24.27 27,957
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock $618,688

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex